Androgen receptor (AR) signaling [4] is the key cause of benign prostate hyperplasia (BPH), prostate cancer initiation, and progression of disease due to malfunctioned testosterone metabolism and its conversion to dihydrotestosterone in the presence of 5α reductase. Here, AR is linked to prostate carcinoma.